After working this past year to pair up its rapid COVID-19 antigen test with digital smartphone capabilities, BD is making its relationship with Scanwell Health official. The medtech giant acquired…
Cytokinetics has found another company that still sees a future for its heart failure prospect omecamtiv mecarbil. After losing partnerships with Amgen and Servier in quick succession,…
Pfizer reported the death of a young male patient who was participating in an an early-stage trial for the Big Pharma’s Duchenne muscular dystrophy gene therapy. The company paused screening and…
Watch out, Sanofi and Regeneron. Eli Lilly’s Dupixent rival has posted another round of data showing improvement in atopic dermatitis when combined with topical corticosteroids in a phase 3 trial.
A hacking risk discovered last month within the widely used Apache Log4j logging tool has been labeled ‘the single biggest, most critical vulnerability of the last decade’ by the CEO of cybersecurity…
The company would become part of GE’s ultrasound business, expanding its capabilities to include surgical visualization. GE plans to spin out its healthcare division into a publicly traded company in…
Insurers that didn’t meet medical loss ratio requirements have paid out a total of $2 billion in rebates to nearly 10 million people, split between people who received their insurance through…
The FDA has halted tests of a Pfizer gene therapy for Duchenne muscular dystrophy. The clinical hold is one of several placed on gene therapy tests in the past year due to safety concerns.
What draws investors to healthcare startups? In this series in the runup to MedCity INVEST in Chicago, we’ll highlight these perspectives. If you’re a startup in pharma tech, value-based care and care…
The Covid-19 pandemic has brought a laser focus to the critical and immediate need for next-generation sequencing tools that can generate invaluable data for not only identifying emerging variants but…
